UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

164 Insulin-Like Growth Factors and Their Binding Proteins in Early Milk from Mothers of Preterm and Term Infants and Thei Biological Relevance

Pediatric research, 2004-09, Vol.56 (3), p.492-492

2004

Volltextzugriff (PDF)

Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus

Archives of disease in childhood, 2001-04, Vol.84 (4), p.369-372

2001

Volltextzugriff (PDF)

Auxological and endocrinological evaluation of children with hydrocephalus and/or meningomyelocele

European journal of pediatrics, 1997-08, Vol.156 (8), p.597-601

1997

Volltextzugriff (PDF)

Wachstumshormonmangel bei Prader-Labhart-Willi-Syndrom : Fallbericht

Monatsschrift Kinderheilkunde, 1996-07, Vol.144 (7), p.707-710

1996

Volltextzugriff (PDF)

One-year treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: a comparison of supine length and arm span

Journal of Pediatric Endocrinology and Metabolism, 1999-03, Vol.12 (2), p.153

1999

Volltextzugriff (PDF)

Visual Loss As a First Sign of Adult-Type Chronic Myeloid Leukemia in a Child

American journal of ophthalmology, 2005-10, Vol.140 (4), p.750-751

2005

Volltextzugriff (PDF)

Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus

Child's nervous system, 2002-04, Vol.18 (3-4), p.137-141

2002

Volltextzugriff (PDF)

Insulin-like-growth-Faktoren (IGF) und Bindungsproteine (IGFBP) in Muttermilch von Früh- und Reifgeborenen

Zeitschrift für Geburtshilfe und Neonatologie, 2004, Vol.208 (S 1)

2004

Volltextzugriff (PDF)

CHILDREN WITH MENINGOMYELOCELE AND GROWTH HORMONE DEFICIENCY: THREE-YEAR-RESULTS OF TREATMENT WITH RECOMBINANT HUMAN GROWTH HORMONE

Pediatric research, 1999-06, Vol.45 (6), p.915-915

1999

Volltextzugriff (PDF)

Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus

BMC pediatrics, 2001, Vol.1 (1), p.2-2, Article 2

2001

Volltextzugriff (PDF)

Treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: 2-year results

Growth hormone & IGF research, 1998-08, Vol.8 (4), p.320-320

1998

Volltextzugriff (PDF)

The concept of treatment-free remission in chronic myeloid leukemia

Leukemia, 2016-08, Vol.30 (8), p.1638-1647

2016

Volltextzugriff (PDF)

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

The New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796

2013

Volltextzugriff (PDF)

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Leukemia, 2020-04, Vol.34 (4), p.966-984

2020

Volltextzugriff (PDF)

Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation

Leukemia, 2020-07, Vol.34 (7), p.1723-1725

2020

Volltextzugriff (PDF)

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2017-07, Vol.28 (suppl_4), p.iv41-iv51

2017

Volltextzugriff (PDF)

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Leukemia, 2015-05, Vol.29 (5), p.999-1003

2015

Volltextzugriff (PDF)

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

Leukemia, 2015-05, Vol.29 (5), p.1123-1132

2015

Volltextzugriff (PDF)

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

The New England journal of medicine, 2017-03, Vol.376 (10), p.917-927

2017

Volltextzugriff (PDF)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Volltextzugriff (PDF)

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

Leukemia, 2017-04, Vol.31 (4), p.829-836

2017

Volltextzugriff (PDF)

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

Leukemia, 2017-03, Vol.31 (3), p.593-601

2017

Volltextzugriff (PDF)

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

Leukemia, 2016-08, Vol.30 (8), p.1648-1671

2016

Volltextzugriff (PDF)

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Leukemia, 2017-07, Vol.31 (7), p.1525-1531

2017

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(280)
Mit Volltextzugriff
(274)

Publikationsform

Sprache

Englisch
(283)
Japanisch
(32)
Deutsch
(11)

Erscheinungsjahr

n.n

Thema

Science & Technology
(137)
Life Sciences & Biomedicine
(130)
Humans
(127)
Hematology
(90)
Male
(79)
Female
(74)
Middle Aged
(73)
Oncology
(73)
Aged
(69)
Adult
(67)
Biological And Medical Sciences
(58)
Medical Sciences
(57)
Leukemia
(51)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Drug Therapy
(45)
Chronic Myeloid Leukemia
(41)
Treatment Outcome
(36)
Adolescent
(34)
Aged, 80 And Over
(32)
Leukemia, Myelogenous, Chronic, Bcr-Abl Positive - Genetics
(32)
Patients
(32)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

164 Insulin-Like Growth Factors and Their Binding Proteins in Early Milk from Mothers of Preterm and Term Infants and Thei Biological Relevance

Increased cerebrospinal fluid concentrations of soluble Fas (CD95/Apo-1) in hydrocephalus

Auxological and endocrinological evaluation of children with hydrocephalus and/or meningomyelocele

Wachstumshormonmangel bei Prader-Labhart-Willi-Syndrom : Fallbericht

One-year treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: a comparison of supine length and arm span

Visual Loss As a First Sign of Adult-Type Chronic Myeloid Leukemia in a Child

Vascular endothelial growth factor and erythropoietin concentrations in cerebrospinal fluid of children with hydrocephalus

Insulin-like-growth-Faktoren (IGF) und Bindungsproteine (IGFBP) in Muttermilch von Früh- und Reifgeborenen

CHILDREN WITH MENINGOMYELOCELE AND GROWTH HORMONE DEFICIENCY: THREE-YEAR-RESULTS OF TREATMENT WITH RECOMBINANT HUMAN GROWTH HORMONE

Elevated nerve growth factor and neurotrophin-3 levels in cerebrospinal fluid of children with hydrocephalus

Treatment with recombinant human growth hormone of children with meningomyelocele and growth hormone deficiency: 2-year results

The concept of treatment-free remission in chronic myeloid leukemia

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia

Holding CoVID in check through JAK? The MPN-approved compound ruxolitinib as a potential strategy to treat SARS-CoV-2 induced systemic hyperinflammation

Chronic myeloid leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Laboratory recommendations for scoring deep molecular responses following treatment for chronic myeloid leukemia

Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV

A phase 3, open-label, randomized study of asciminib, a STAMP inhibitor, vs bosutinib in CML after 2 or more prior TKIs

Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

European LeukemiaNet recommendations for the management and avoidance of adverse events of treatment in chronic myeloid leukaemia

Treatment-free remission following frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the ENESTfreedom study

Suchergebnisse filtern